巨细胞病毒血症可预测肯尼亚HIV暴露未感染儿童出院后死亡
在1024名1-59月龄肯尼亚出院儿童中(含97名HIV暴露未感染[HEU]和15名HIV感染儿童),检测血浆巨细胞病毒(CMV)DNA水平,用泊松回归和Cox比例风险回归分析CMV病毒血症≥1000 IU/mL的相关因素及与6个月死亡率的关系。HEU儿童中CMV≥1000 IU/mL(HR=32.0;95%CI,2.9-354.0;P=.005)及CMV病毒载量每增加1个log(HR=5.04;95%CI,1.7-14.6;P=.003)与死亡风险增加相关;HIV未暴露儿童中CMV病毒血症与死亡率无显著关联。
要点
- 31%出院儿童检出CMV病毒血症,5.8%水平≥1000 IU/mL。
- HEU儿童CMV≥1000 IU/mL与6个月死亡风险增加相关(HR=32.0)。
- HEU儿童CMV病毒载量每增加1个log与死亡风险增加相关(HR=5.04)。
核心结论
- 出院时CMV水平可预测肯尼亚HEU儿童6个月死亡风险增加;抑制CMV可能是降低HEU儿童死亡率的新靶点。
研究设计与样本
- 在1024名1-59月龄肯尼亚出院儿童中检测血浆CMV DNA水平,其中97名为HIV暴露未感染(HEU),15名为HIV感染儿童;采用泊松回归和Cox比例风险回归分别识别CMV病毒血症≥1000 IU/mL的相关因素和估计与6个月死亡率的关联。
主要发现
- 31%的儿童检出CMV病毒血症,5.8%的儿童CMV水平≥1000 IU/mL。
- HIV感染、年龄<2岁、母乳喂养和中上臂围<12.5 cm与CMV病毒血症≥1000 IU/mL相关。
- HEU儿童中CMV≥1000 IU/mL与死亡风险增加相关(HR=32.0;95%CI,2.9-354.0;P=.005)。
- HEU儿童中CMV病毒载量每增加1个log与死亡风险增加相关(HR=5.04;95%CI,1.7-14.6;P=.003)。
- HIV未暴露儿童中CMV病毒血症与死亡率无显著关联。
关键数值与推荐
- HEU儿童CMV≥1000 IU/mL的6个月死亡HR=32.0(95%CI,2.9-354.0;P=.005)。
- HEU儿童CMV病毒载量每增加1个log的6个月死亡HR=5.04(95%CI,1.7-14.6;P=.003)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cytomegalovirus (CMV) viremia is associated with mortality in severely ill immunocompetent adults and hospitalized children with HIV (CWH). We measured CMV viremia in HIV-exposed and -unexposed Kenyan children aged 1-59 months discharged from hospital and determined its relationship with postdischarge mortality. METHODS: CMV DNA levels were measured in plasma from 1024 children (97 of which were HIV exposed uninfected [HEU], and 15 CWH). Poisson and Cox proportional hazards regression models were used to identify correlates of CMV viremia ≥ 1000 IU/mL and estimate associations with 6-month mortality, respectively. RESULTS: CMV viremia was detected in 31% of children, with levels ≥ 1000 IU/mL in 5.8%. HIV infection, age < 2 years, breastfeeding, and midupper arm circumference < 12.5 cm were associated with CMV viremia ≥ 1000 IU/mL. Among HEU children, CMV ≥ 1000 IU/mL (hazard ratio [HR] = 32.0; 95% confidence interval [CI], 2.9-354.0; P = .005) and each 1-log increase in CMV viral load (HR = 5.04; 95% CI, 1.7-14.6; P = .003) were associated with increased risk of mortality. CMV viremia was not significantly associated with mortality in HIV-unexposed children. CONCLUSIONS: CMV levels at hospital postdischarge predict increased risk of 6-month mortality in Kenyan HEU children. CMV suppression may be a novel target to reduce mortality in HEU children. CLINICAL TRIAL REGISTRATION: NCT02414399.
引用
- Pavlinac PB, Singa B, Huang ML, et al. Cytomegalovirus Viremia Predicts Postdischarge Mortality in Kenyan HIV-Exposed Uninfected Children. J Infect Dis. 2022. PMID: 35152295. doi:10.1093/infdis/jiac047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。